We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-1 of 1

ECJ rules on dual pricing of medicines

  • Fried Frank Harris Shriver & Jacobson LLP
  • -
  • European Union, Spain
  • -
  • November 13 2009

The ECJ confirmed that the dual pricing policy implemented by GlaxoSmithKline ("Glaxo") in Spain could potentially be exempted from competition rules